RegainMemory
  • Home
  • Research
  • Explore Tools
  • C-RM360
  • LICCA
  • Resources
  • More
    • Home
    • Research
    • Explore Tools
    • C-RM360
    • LICCA
    • Resources
RegainMemory
Explore Cognitive Tools
  • Home
  • Research
  • Explore Tools
  • C-RM360
  • LICCA
  • Resources
Explore Cognitive Tools

Dr. Kumar’s Systematic Research of 20 Years in Memory Loss..

Suresh Kumar MD. FAAN. Diplomate ABPN-TBIM

 Dr. Suresh Kumar, MD, FAAN, Diplomate ABPN–TBIM, is a triple board-certified neurologist, researcher, and inventor of Regain Memory 360 (RM360), an innovative AI-guided cognitive evaluation and brain rehabilitation platform focused on memory disorders, traumatic brain injury (TBI), concussion, headaches, and neurocognitive recovery. With more than 20 years of clinical and research experience in Louisiana and Texas, Dr. Kumar has dedicated his career to advancing digital cognitive assessment and personalized brain recovery systems through tools such as DMAC, S-DMAC, and LICCA. His research integrates neuroscience, neuroplasticity, AI-assisted cognitive therapy, and body–brain optimization to improve outcomes in patients with dementia, TBI, post-concussion syndrome, ADHD, and cognitive decline. Dr. Kumar has presented his work nationally at leading neurology conferences, including the American Academy of Neurology, and continues to lead research initiatives focused on accessible, at-home cognitive screening and brain rehabilitation technologies designed to enhance quality of life and cognitive resilience worldwide. 

Cognitive / Memory Testing Research

  1. Diagnostic Accuracy of a Digitally Assisted Mobile Cognitive Assessment for Memory Impairment: Southern Gerontology Society April 2026 Dallas/ AAIC July 2026 London, UK
  2. Correlation of the cognitive impairment in former NFL players with positions & concussions: S. Kumar, M. Jaiswal, A. Kumar. Poster presentation @ ACRM Sept. 2018.
  3. Montreal Cognitive Assessment, a screening tool for Mild Traumatic Brain Injury. S. Kumar MD, A Jawahar MS, P Shah BS, M Kumar DDS ~ American Academy of neurology, Washington DC AAN .2015
  4. Association between etiology and patterns of neurocognitive impairment detected with Wechsler Memory Scale (WMS-IV) assessment: Prospective study in 71 consecutive patients A Jawahar MS S. Kumar MD, P Shah BS, M Kumar DDS ~ presented at American Academy of neurology, Washington DC AAN .2015
  5. Brain Injury cognitive screening is a spot tool for mild traumatic brain injury. Jeet B MS. S. Kumar MD, A. Jawahar ~ presented at AMIA Joint Summit  San Francisco, CA  2015
  6. Doc, Do I have a brain injury? MoCA an effective screening tool for outpatient Clinics. 86 TBI patients’ prospective study, Oral Presentation, Brain injury Association of Canada, Quebec Sept 2014 .

Brain-Body Optimization -Modifiable Risk Factors

 

  1. Modifiable Risk factor of late onset Alzheimer's disease: A Retrospective observational study 2026
  2. The Importance of Vitamin D in Beta-Amyloid Clearance in Late onset Alzheimer’s Disease. AAIC London 2026
  3. The Effect of Vitamin D and Homocysteine on DNA Regulation of Beta-Amyloid AAIC London 2026
  4. Correlation of Cognitive Impairment with the Aβ42/40 Peripheral Blood Biomarker: American Academy of Neurology Chicago April 2026
  5. 'Hyperhomocysteinemia: A Risk Factor for Cognitive Decline in mTBI Patients'.S. Kumar M.D., S. Shah, P Chalamalasetty A. Kumar. presentation @ Virtual American Academy of Neurology Sports Concussion 2020 
  6. New IDEAS-2 Study protocol was developed and approved as a Coverage with Evidence Development (CED) Study under the supervision of the Centers for Medicare & Medicaid Services (CMS). Clinical site for patient recruitment, Practice Name: Neurology and Headache Center 2022
  7. The New IDEAS (Imaging Dementia—Evidence for Amyloid Scanning) Study is managed by the American College of Radiology Practice ID#: 2278, Practice Name: Neurology and Headache Center 2019
  8. Early Dementia and Epigenetics of Alzheimer's disease a Clinical Approach: S. Kumar, S. Shah, A. Kumar. Poster presentation @ AAIC July. 2019.
  9. Relevance of Well-Defined Laboratory Tests Memory Panel in Dementia Workup: S. Kumar, S. Shah, A. Kumar. Poster presentation @ AAIC July. 2019.
  10. PI & Protocol contributor. 17-AVP-786-205 A Phase 2, multicenter, randomized, double-blind,placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of neurobehavioral disinhibition, including aggression, agitation, and irritability, in patients with traumatic brain injury (TBI). :Avanir Pharmaceutical 2018
  11. Cognitive impairment in Former NFL players independent of aging: S. Kumar, S. Shah, A. Kumar. Poster presentation @ ACRM Sept. 2018
  12. Prevalence of Mood Disorder in Former NFL Players: S. Kumar, R. Gupta, S. Shah, A. Kumar. Poster presentation @ ACRM Sept. 2018.
  13. Forensic value of MRS/DTI MRI with Neuro-Cognitive testing in mTBI Patients, S. Kumar, R. Gupta, S. Shah, A. Kumar. Poster presentation @ ACRM Sept. 2018.
  14. Functional and Cerebral Metabolites Evaluation of Single Episode mTBI with MRS and DTI : Kumar S , Shah P, Boles W , Kumar M : Podium/oral presentation. March IBIA2017, New Orleans/ Europe TBI conference London 2017,
  15. Risk of Depression following mTBI: Kumar S , Stephens J , Shah P, Boles W , Kumar M , Brigham M: Headache, Podium/oral presentation. USA March IBIA 2017, New Orleans/ Europe TBI conference London 2017, 
  16. Late Seizures in mTBI: A Prospective Study: Kumar S , Shah P, Boles W , Kumar M: Podium/oral presentation, New Orleans/ Europe TBI conference London 2017, March IBIA2017
  17. Seizures after mild traumatic brain Injury in general population-Prospective study S. Kumar MD, P Shah BS, M Kumar DDS presented at AAN . Sports concussion conference, American Academy of neurology, Chicago.July 2016
  18. Seizure in Mild traumatic brain injury: prospective analysis of 123 patients in TBI outpatient clinic. S. Kumar MD, A. Jawahar MD ~ presented at TBI Conference of America Washington DC April 2015.
  19. "post-concussion syndrome & BPPV presenting with migraine/headaches in an urgent headache clinic: Analysis of 90 cases, S. Kumar MD ~poster presentation.2014 annual meeting of American Headache Society. Los Angeles, CA
  20. Central pontine myelinolysis, an update Kumar, Suresh1; Fowler, Marjorie2; Gonzalez-Toledo, Eduardo3; Jaffe, S.L, Neurological Research, Volume 28, Number 3, pp. 360-366(7) Department of Neurology, Louisiana State University School of Medicine, Shreveport, 71103, USA  April 2006,  

Cognitive Training & Therapy

 

  1. Effectiveness of AI-Guided Technology-Assisted Cognitive Therapy in Improving Memory in Mild to Moderate Dementia and Traumatic Brain Injury: A Retrospective longitudinal pre-post intervention effectiveness study. Southern Gerontology Society April 2026,  AAIC London July 2026
  2. The Importance of Vitamin D in Beta-Amyloid Clearance in Late onset Alzheimer’s Disease. AAIC London 2026
  3. The Effect of Vitamin D and Homocysteine on DNA Regulation of Beta-Amyloid AAIC London 2026
  4. Online Cognitive Therapy in patients with memory loss after TBI.S. Kumar MD, P Shah BS, J Lachney BS, M Kumar DDS AAN .Sports concussion conference, American Academy of neurology, Chicago. July 2016 
  5. Observed Specific Pattern of cognitive impairment in patients with Mild Traumatic Brain Injury: a prospective study of 35 patients, A Jawahar MS S. Kumar MD, P Shah BS, M Kumar DDS ~  American Academy of neurology, Washington DC. AAN .2015 
  6. Individualized neuro-cognitive rehabilitation can reverse cognitive and memory impairment irrespective of etiology: Prospective pilot study. S. Kumar MD, Jitendra K, MS. A Jawahar MS, , M Kumar DDS ~ American Academy of neurology, Washington DC AAN .2015

Other Research & Lecture Activity ..

  

  1. Risk Stratification of Hypertension Induced by CGRP Antagonists  in Migraine Treatment: American Academy of Neurology Chicago April 2026
  2. PI & Protocol contributor. 17-AVP-786-205 A Phase 2, multicenter, randomized, double-blind,placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of neurobehavioral disinhibition, including aggression, agitation, and irritability, in patients with traumatic brain injury (TBI). :Avanir Pharmaceutical 2018
  3. PI . Biohaven BHV3000-311 Active Adolescent headache study Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents ≥ 6 to <18 years of age. 
  4. Central pontine myelinolysis, an update Kumar, Suresh1; Fowler, Marjorie2; Gonzalez-Toledo, Eduardo3; Jaffe, S.L, Neurological Research, Volume 28, Number 3, pp. 360-366(7) Department of Neurology, Louisiana State University School of Medicine, Shreveport, 71103, USA April 2006,
  5. "Complement Dependent Cytotoxicity Cross match (CDC) at 4°C, 22°C & 37°C in Renal Transplant Patients." Principal Investigator: Suresh Kumar, MD. MRCP accepted and poster presentation to AFMR Southern Meeting in 2002. 
  6. "Positive B Cell Cross Math and Renal Transplant Outcome." Principal Investigator: Suresh Kumar, MD. MRCP accepted a poster presentation to AFMR Southern Meeting in 2002.

Lectures in Conference and symposium 

  1. Research Lecture Presentation Effectiveness of AI-Guided Technology-Assisted Cognitive Therapy in Improving Memory in Mild to Moderate Dementia and Traumatic Brain Injury: A Retrospective longitudinal pre-post intervention effectiveness study.
  2. American Academy of Neurology April 2015: Montreal Cognitive Assessment, a screening tool for Mild Traumatic Brain Injury. S. Kumar MD, A Jawahar MS, P Shah BS, M Kumar DDS ~ presented at AAN .2015 American Academy of neurology, Washington DC
  3. Chair 3rd International Conference on neurological disorder & Brain Injury, London UK April 3 Dr. Suresh Kumar CV 2017, Euro Brain Injury Series Conferences
  4. Regain Memory after Mild traumatic brain Injury, Symposium Euro Brain Injury 2017 
  5. Doc, Do I have a brain injury? MoCA an effective screening tool for outpatient Clinics. 86 TBI patients’ prospective study, Oral Presentation, Brain injury Association of Canada, Quebec Sept 2014 .
  6. . Introduction and Evolution of cognition, Symposium Memory Loss April 5th 2016, Wyndham hotel, Shreveport 
  7. Advance treatment of in Memory Loss, Symposium Memory Loss April 5th 2016, Wyndham hotel, Shreveport 
  8. Nutrition Therapy in memory loss, Symposium Memory Loss April 5th 2016, Wyndham hotel, Shreveport
  9. Mild Traumatic Brain Injury to regain Memory LSU Dept Of Orthopedics Grand Rounds 9/25/2015 
  10. Regain memory after TBI, Barksdale Air force base, Medical building Lunch & Learn April 2015.
  11. Posttraumatic headaches/Mild traumatic brain injury LSU Dept of Neurology Grand rounds 4/12/13 
  12. Thalamus an enigma: Grand rounds 2006 injury LSU Dept of Neurology Grand rounds 2006 8. Intracranial hemorrhage: A disease of many challenges LSU Dept of Neurology Grand rounds 2007 Neuroscience Lecture LSUHSC Shreveport, LA dept of neurology 2013, 2010, 2009,2008 

Copyright © 2026 RegainMemory360 - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept